Relative gene expression of NF-κB and TNF-α were significantly increased in MS compared to CTRL, while DATS treatment significantly decreased the relative gene expression of NF-κB and IL-17A (Figure 9c). This evidence concerns the gene IL17A and myeloid sarcoma.